PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-3010

  1. 1,216 Posts.
    lightbulb Created with Sketch. 1375
    It also needs to be pointed out that the original post assumed 100% bioavailability via SQ injection, while bioavailability is more likely to be less than half of that, which we won't know until the PK studies are completed.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.